231 related articles for article (PubMed ID: 37847741)
21. Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen.
Ochsenreither S; Majeti R; Schmitt T; Stirewalt D; Keilholz U; Loeb KR; Wood B; Choi YE; Bleakley M; Warren EH; Hudecek M; Akatsuka Y; Weissman IL; Greenberg PD
Blood; 2012 Jun; 119(23):5492-501. PubMed ID: 22529286
[TBL] [Abstract][Full Text] [Related]
22. Genetic Modification of Limbal Stem Cells to Decrease Allogeneic Immune Responses.
Valdivia E; Bertolin M; Breda C; Carvalho Oliveira M; Salz AK; Hofmann N; Börgel M; Blasczyk R; Ferrari S; Figueiredo C
Front Immunol; 2021; 12():747357. PubMed ID: 34956181
[TBL] [Abstract][Full Text] [Related]
23. A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid Leukemia Cells.
Guinn BA; Schuler PJ; Schrezenmeier H; Hofmann S; Weiss J; Bulach C; Götz M; Greiner J
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298237
[TBL] [Abstract][Full Text] [Related]
24. A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.
Pei S; Shelton IT; Gillen AE; Stevens BM; Gasparetto M; Wang Y; Liu L; Liu J; Brunetti TM; Engel K; Staggs S; Showers W; Sheth AI; Amaya ML; Minhajuddin M; Winters A; Patel SB; Tolison H; Krug AE; Young TN; Schowinsky J; McMahon CM; Smith CA; Pollyea DA; Jordan CT
Cancer Discov; 2023 Sep; 13(9):2032-2049. PubMed ID: 37358260
[TBL] [Abstract][Full Text] [Related]
25. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
Al-Mawali A; Gillis D; Lewis I
J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
[TBL] [Abstract][Full Text] [Related]
26. [Expression of Th17 and IL-23 in Peripheral Blood and Their Relationship with Immunophenotype in Patients with Acute Myeloid Leukemia].
Peng ZY; Yang CX; San JH; Li QQ; Zhang MM; Shi B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1056-1062. PubMed ID: 35981362
[TBL] [Abstract][Full Text] [Related]
27. An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells.
Sergeeva A; Alatrash G; He H; Ruisaard K; Lu S; Wygant J; McIntyre BW; Ma Q; Li D; St John L; Clise-Dwyer K; Molldrem JJ
Blood; 2011 Apr; 117(16):4262-72. PubMed ID: 21296998
[TBL] [Abstract][Full Text] [Related]
28. A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia.
Zhang M; Sukhumalchandra P; Enyenihi AA; St John LS; Hunsucker SA; Mittendorf EA; Sergeeva A; Ruisaard K; Al-Atrache Z; Ropp PA; Jakher H; Rodriguez-Cruz T; Lizee G; Clise-Dwyer K; Lu S; Molldrem JJ; Glish GL; Armistead PM; Alatrash G
Clin Cancer Res; 2013 Jan; 19(1):247-57. PubMed ID: 23147993
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
[TBL] [Abstract][Full Text] [Related]
30. The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML.
von Palffy S; Thorsson H; Peña-Martínez P; Puente-Moncada N; Sandén C; Blom AM; Henningsson R; Juliusson G; King B; Landberg N; Lazarevic V; Orsmark-Pietras C; Rissler M; Rissler V; Ågerstam H; Järås M; Lilljebjörn H; Fioretos T
Blood Adv; 2023 Apr; 7(7):1204-1218. PubMed ID: 36383712
[TBL] [Abstract][Full Text] [Related]
31. Acute Myeloid Leukemia Stem Cell Heterogeneity and Its Clinical Relevance.
Karantanos T; Jones RJ
Adv Exp Med Biol; 2019; 1139():153-169. PubMed ID: 31134500
[TBL] [Abstract][Full Text] [Related]
32. Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches.
Thakral D; Gupta R; Khan A
Stem Cell Rev Rep; 2022 Jun; 18(5):1756-1773. PubMed ID: 35412219
[TBL] [Abstract][Full Text] [Related]
33. [Determination of leukemia stem cells in childhood acute myeloid leukemia and its clinical significance].
Wang D; Tang YM; Xu XJ; Shen HQ; Qian BQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):952-8. PubMed ID: 20723307
[TBL] [Abstract][Full Text] [Related]
34. Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia.
Han H; Byun JM; Shin DY; Yoon SS; Koh Y; Hong J; Kim I; Lee C; Yoo H; Yun H; Kim MJ; Cho SI; Seong MW; Park SS
Korean J Intern Med; 2021 Mar; 36(2):401-412. PubMed ID: 32811132
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication.
de Leeuw DC; Denkers F; Olthof MC; Rutten AP; Pouwels W; Schuurhuis GJ; Ossenkoppele GJ; Smit L
Cancer Res; 2014 Apr; 74(7):2094-105. PubMed ID: 24477595
[TBL] [Abstract][Full Text] [Related]
36. Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.
Moshaver B; Wouters RF; Kelder A; Ossenkoppele GJ; Westra GAH; Kwidama Z; Rutten AR; Kaspers GJL; Zweegman S; Cloos J; Schuurhuis GJ
Leuk Res; 2019 Jun; 81():27-34. PubMed ID: 31002948
[TBL] [Abstract][Full Text] [Related]
37. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
[TBL] [Abstract][Full Text] [Related]
38. Targeting Immunophenotypic Markers on Leukemic Stem Cells: How Lessons from Current Approaches and Advances in the Leukemia Stem Cell (LSC) Model Can Inform Better Strategies for Treating Acute Myeloid Leukemia (AML).
Mitchell K; Steidl U
Cold Spring Harb Perspect Med; 2020 Jan; 10(1):. PubMed ID: 31451539
[TBL] [Abstract][Full Text] [Related]
39. AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells.
Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH
Clin Cancer Res; 2017 Jun; 23(11):2781-2794. PubMed ID: 27864418
[No Abstract] [Full Text] [Related]
40. Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia.
Forghieri F; Riva G; Lagreca I; Barozzi P; Bettelli F; Paolini A; Nasillo V; Lusenti B; Pioli V; Giusti D; Gilioli A; Colasante C; Galassi L; Catellani H; Donatelli F; Talami A; Maffei R; Martinelli S; Potenza L; Marasca R; Tagliafico E; Manfredini R; Trenti T; Comoli P; Luppi M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
